Identity
- Security key
- 17084
- Ticker
- INDV
- Type
- CS — Common Stock
- Exchange
- Nasdaq(XNAS)
- Venue group
- NASDAQ
- Operating MIC
- XNAS
- Market
- stocks
- Locale
- us
- Currency
- USD
- Listed
- 2014-12-24
- Round lot
- 100
- Active
- Yes
- Last seen in a load
- 2026-08-14 20:49
- Vendor updated
- 2026-08-13 06:09
- Ticker root / suffix
- INDV
Detail
Enriched 2026-08-14 20:47
- Market cap
- $4,570,668,625.77
- Shares outstanding (class)
- 118,013,649
- Shares outstanding (weighted)
- 118,013,649
- SIC
- 2834 PHARMACEUTICAL PREPARATIONS
- Employees
- 838
- Location
- NORTH CHESTERFIELD, VA
- Homepage
- https://www.indivior.com
- Description
Indivior Pharmaceuticals Inc is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The company derives revenues from customers through the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence and related disorders. The company's products include: Sublocade (buprenorphine extended-release monthly injection), and Suboxone (buprenorphine and naloxone sublingual film).